AUSTRALIAN CLINICAL LABS LIMITED (ACL)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

ACL - AUSTRALIAN CLINICAL LABS LIMITED
FNArena Sector : Healthcare services
Year End: June
GICS Industry Group : Health Care Equipment & Services
Index: ASX300 | ALL-ORDS
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$3.01
30 Jan |
0.000 OPEN $3.01 |
0.000 HIGH $3.01 |
0 LOW $3.01 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
EBO . SLA . CAJ . GXL . HSO . MPL . MVF . NHF . HLS . RHC . SHL . VRT . MDR . M7T . HLA . PSQ . SIL . PKS . ONT . DOC . BMT . NVL . AHX . ALC . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY21 Actual |
FY22 Actual |
FY23 Forecast |
FY24 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | 88.6 | 22.4 | xxx |
DPS (cps) | xxx | 53.0 | N/A | xxx |
EPS Growth | xxx | 100.0% | - 74.7% | xxx |
DPS Growth | xxx | 100.0% | N/A | xxx |
PE Ratio | xxx | N/A | 13.4 | xxx |
Dividend Yield | xxx | N/A | 0.0% | xxx |
Div Pay Ratio(%) | xxx | 59.9% | 0.0% | xxx |
Last ex-div: 23/08 - ex-div 41c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | 88.6 |
DPS All | xxx | xxx | xxx | 53.0 |
Sales/Revenue | xxx | xxx | xxx | 989.3 M |
Book Value Per Share | xxx | xxx | xxx | 115.8 |
Net Operating Cash Flow | xxx | xxx | xxx | 284.1 M |
Net Profit Margin | xxx | xxx | xxx | 18.02 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | 113.41 % |
Return on Invested Capital | xxx | xxx | xxx | 50.49 % |
Return on Assets | xxx | xxx | xxx | 32.33 % |
Return on Equity | xxx | xxx | xxx | 113.41 % |
Return on Total Capital | xxx | xxx | xxx | 61.46 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | 238.6 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
This is work in progress. Bear with us. It'll be amazing.
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
ACL STOCK CHART

FNArena News on ACL
1 |
Rudi’s View: Re-Opening Opportunities In HealthcareNov 17 2022 - Rudi's View |
2 |
Australian Broker Call *Extra* Edition – Nov 09, 2022Nov 09 2022 - Daily Market Reports |
3 |
Rudi’s View: Technology’s Moment Of TruthNov 03 2022 - Rudi's View |
4 |
Australian Broker Call *Extra* Edition – Oct 28, 2022Oct 28 2022 - Daily Market Reports |
5 |
In Brief: Consumer Spending, NZ Blueprint, Less Covid TestingSep 16 2022 - Weekly Reports |
Latest Healthcare services News
1 |
Dr Boreham’s Crucible: AlcidionDec 13 2022 - Small Caps |
2 |
No Straight Covid-Relief For Ramsay Health CareNov 15 2022 - Australia |
3 |
Dr Boreham’s Crucible: Mach7 TechnologiesNov 14 2022 - Small Caps |
4 |
Negative Industry Trends Impact Australian Clinical LabsAug 12 2022 - Small Caps |
5 |
Healius Offers Digital Carrot, Base Remains SoftMay 25 2022 - Australia |
6 |
Ramsay Stakes Future on Mental HealthDec 20 2021 - Australia |
7 |
Ramsay Health Care: Finally A Break-OutNov 09 2021 - Technicals |
8 |
Funding Overhang Weighs On Ramsay’s ReboundJun 10 2021 - Australia |
9 |
Treasure Chest: More Pfizer Growth For Ebos GroupMay 24 2021 - Treasure Chest |
10 |
Treasure Chest: Demand Pumps Ramsay HealthMar 03 2021 - Treasure Chest |